Science Vs. Politics: Hearing Could Reveal Makary’s Approach To Unusual Administration Involvement

 
• By Sarah Karlin-Smith

US FDA Commissioner nominee Martin Makary’s 6 March Senate confirmation hearing should offer insight on his alignment with HHS Secretary Robert F. Kennedy Jr.'s views and willingness to insulate the FDA from an unusual level of micromanagement by the department and White House.

empty US Senate hearing room
FDA Commissioner nominee Martin Makary will answer questions from the Senate HELP Committee on 6 March. (Katherine Welles/Shutterstock)

More from US FDA

More from Vaccines